Business Daily from THE HINDU group of publications
Saturday, Oct 21, 2006

Cross Currency

Group Sites

Marketing - New Products & Services
Sterilox tech unveiled in India

Our Bureau

Hyderabad, Oct. 18

Sterilox, which is considered a new international biocide technology patented and approved by the USFDA, was unveiled here by the Delhi-based Jodhana Medical & Research Centre (JMRC). According to the President and CEO of Sterilox UK, Mr Paul J. Donnelly, the biocide is versatile, effective and fast acting in controlling bacteria, thereby keeping foods fresher for longer hours and enhancing hygiene. It has a wide range of uses in supermarkets, restaurants, hotels, hospitals and clinics, he said.

Stating that Sterilox is more cost-effective than the conventional chemical biocides, he said it has become the biocide of choice in leading international supermarkets, hotels, restaurants, hospitals and clinics. "It has great potential in India, where it can help players in the rapidly growing retail, hospitality and healthcare industries transform their operations and develop a significant competitive edge," he said.

More Stories on : New Products & Services | Chemicals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Airtel to launch mall service soon

Sony plans reality show Big Boss
Mother Dairy: Clarification
O&M plans hires from tier-II centres
`Modern format stores witness sizeable growth'
Rajesh Exports opens more outlets
`Innovative promotions register top-of-mind recall'
United Spirits to check counterfeit brands with super cap
`Market for home theatres growing'
Sterilox tech unveiled in India

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line